Pipeline

At the heart of Charleston Laboratories lies our product pipeline. Designed with one purpose: to treat acute pain while preventing and reducing the common side effects of nausea and vomiting, providing patients with appropriate pain relief while ensuring a timely and smooth recovery.

Acute Pain Learn More
CL-108 (Hydrocodone / APAP / Promethazine) 7.5 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-108 (Hydrocodone / APAP / Promethazine) 5 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-108 (Hydrocodone / APAP / Promethazine) 10 mg DOSE Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLOX-315 (Oxycodone / Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLP-417 (Tramadol / Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CLP-517 (Hydromorphone / Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Central Nervous System Learn More
CL-H1T (Sumatriptan / Promethazine) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-H2T (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Respiratory Learn More
CL-AT-313 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-AT-413 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
CL-AT-513 (MOLECULE — CONFIDENTIAL) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Abuse-Deterrent Formulations Learn More
Abuse-Deterrence (ABUSE-DETERRENT FORMULATIONS) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide
Research Collaborations Learn More
Stanford Collaboration (STANFORD UNIVERSITY COLLABORATION) Partnership
Pre-Clinical Phase I Phase II Phase III NDA FILED FDA APPROVAL Available
Worldwide